期刊文献+

盐酸头孢替安致Stevens-Johnson综合征 被引量:3

Stevens-Johnson syndrome caused by cefotiam hydrochloride
原文传递
导出
摘要 1例61岁女性患者因慢性胆囊炎急性发作给予盐酸头孢替安2g+0.9%氯化钠注射液100 ml,2次/d静脉滴注;泮托拉唑60 mg+0.9%氯化钠注射液100 ml,2次/d静脉滴注。第2天,患者体温升高,面部及四肢出现红斑样皮疹伴瘙痒。停用盐酸头孢替安,静脉注射地塞米松、肌内注射异丙嗪,无明显好转。第3天皮疹波及全身,伴喉头不适、颜面红肿、眼睑水肿、结膜充血。诊断为Stevens-Johnson综合征,停用泮托拉唑,继续行糖皮质激素和抗组胺治疗。第5天,眼睑水肿减轻。第6天,四肢皮疹明显减轻,颜面红肿消退。第9天,患者全身皮疹基本消退。 A 61-year-old woman with acute episodes of chronic cholecystitis received an IV infusion of cefotiam hydrochloride 2.0 g in 0.9% sodium chloride injection 100 ml twice daily, and an IV infusion of pantoprazole 60 mg in 0. 9% sodium chloride injection 100 ml twice daily. On day 2, the patient's body temperature rose, erythematous skin rashes appeared on her face and extremities, accompanied by itching. Cefotiam hydrochloride was stopped. She was treated with IV dexamethasone and IM promethazine. The above symptoms did not markedly improve. On day 3, skin rashes spread over her entire body, accompanied by throat discomfort, facial swelling, palpebral edema, and conjunctival congestion. Stevens-Johnson syndrome was diagnosed. Pantoprazole was stopped, glucocorticoid and antihistamine treatment was continued. On day 5, palpebral edema was relieved. On day 6, rashes on her limbs was significantly improved and facial swelling disappeared. On day 9, her generalized rashes basically subsided.
出处 《药物不良反应杂志》 CSCD 2013年第4期217-218,共2页 Adverse Drug Reactions Journal
关键词 头孢替安 Stevens—Johnson综合征 Cefotiam Stevens-Johnson syndrome
  • 相关文献

参考文献6

二级参考文献43

  • 1王水英,谢晓英.刺五加注射液致眼结膜充血1例[J].医药导报,2005,24(8):686-686. 被引量:4
  • 2国家食品药品监督管理局.关于修订注射用盐酸头孢替安说明书的通知[Z].国食药监注[2006]549号,2006. 被引量:1
  • 3金有豫.药理学[M] 第5版[M].北京:人民卫生出版社,2001.239-240. 被引量:50
  • 4Chung WH, Hung SI, Hong HS, et al. Medical genetics: a marker for Stevens-Johnson syndrome [J]. Nature, 2004, 428(6982): 486. 被引量:1
  • 5Man CB, Kwan P, Baum L, et aL Association between HLA-B*1502 allele and antiepileptic drug-induced cutane- ous reactions in Han Chinese [J]. Epilepsia, 2007, 48(5): 1015-1018. 被引量:1
  • 6Lonjou C, Thomas L, Borot N, etal. A marker for Stevens- Johnson syndrome: ethnicity matters [J]. Pharmacogenom- ics J, 2006, 6(4): 265-268. 被引量:1
  • 7Alfirevic A, Jorgensen AL, Williamson PR, et al. HLA-B locus in Caucasian patients with carbamazepine hypersen- sitivity [J]. Pharmacogenomics, 2006, 7(6): 813-818. 被引量:1
  • 8Locharernkul C, Loplumlert J, Limotai C, et al. Carbam- azepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population [J]. Epilepsia, 2008, 49(12): 2087-2091. 被引量:1
  • 9Kaniwa N, Saito Y, Aihara M, et al. HLA-B locus in Japa- nese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis [J]. Pharmacogenomics, 2008, 9(11): 1617-1622. 被引量:1
  • 10Chang CC, Too CL, Murad S, et al. Association of HLA- B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi- ethnic Malaysian population [J]. Int J Dermatol, 2011, 50(2).. 221-224. 被引量:1

共引文献207

同被引文献30

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部